| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V106454 | Anti-IGFBP2 Antibody (M14) | Anti-IGFBP2 antibody (M14) is a human anti-IGFBP2 monoclonal antibody inhibitor that binds to IGFBP2 with high affinity and blocks its binding to IGF1. | |
|
V117174 | AZD9362 | 1905412-80-7 | AZD9362 is a reversible, ATP-competitive, orally active insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor inhibitor. |
|
V130159 | BIIB022 | BIIB022 is a human IgG4 monoclonal antibody (mAb) that targets IGF1R/CD221. | |
|
V117033 | BMS-577098 | 667402-44-0 | BMS-577098 is an orally effective ATP-competitive insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 value of 0.016 μM. |
|
V131402 | Ceritinib mesylate | 2055376-74-2 | Ceritinib mesylate is a highly selective, orally bioavailable, ATP-competitive ALK tyrosine kinase inhibitor with an IC50 value of 200 pM. |
|
V69510 | Chimaphilin | 482-70-2 | Chimaphilin is an IGF-1R inhibitor (IC50= 0.086 μM). |
|
V116765 | Cibrigirsen | 160614-28-8 | Cibrigirsen is an antisense oligonucleotide that targets the insulin-like growth factor I receptor (IGF-1R). |
|
|
V116859 | Cibrigirsen sodium | Cibrigirsen sodium is an antisense oligonucleotide that targets the insulin-like growth factor I receptor (IGF-1R). | |
|
V131697 | Cibrigirsen sodium scrambled negative control | The Cibrigirsen sodium scrambled negative control is a negative control with the sequence of Cibrigirsen sodium scrambled. | |
|
V93052 | CL-A3-7 | 2763661-39-6 | CL-A3-7 is a virus-cell fusion inhibitor targeting RSV F protein. It works by blocking the interaction between the virus and the host IGF1R, effectively inhibiting the infection of wild-type and K394R mutant RSV. It is suitable for anti-RSV drug development and drug resistance research. |
|
V112671 | Cyclo (Gly-Pro) | 97011-16-0 | Gly-Pro is a cyclic dipeptide. |
|
V135015 | Elegrobart | 2832924-76-0 | Elegrobart is an IgG1-κ monoclonal antibody that targets human insulin-like growth factor 1 receptor (IGF1R). |
|
V115251 | GTx-134 | 1008448-19-8 | GTx-134 is a dual insulin-like growth factor 1 receptor/insulin receptor (IGF-1R/IR) inhibitor with IC50 values of 97 nM for IGF-1R and 187 nM for IR. |
|
V69509 | IGF-1R inhibitor-2 | 1116236-15-7 | IGF-1R inhibitor-2 (example 121) is an inhibitor (blocker/antagonist) of the insulin-like growth factor-1 receptor (IGF-1R). |
|
V137843 | IGF-1R inhibitor-4 | 443097-57-2 | IGF-1R inhibitor-4 is a potent IGF-1R inhibitor with an inhibition rate of 63% at a concentration of 10 μM. |
|
V137844 | IGF-1R inhibitor-5 | 331652-38-1 | IGF-1R inhibitor-5 is a potent IGF-1R inhibitor with an IC50 of 6 μM. |
|
V80351 | IGF-I (24-41) (TFA) (Insulin-like Growth Factor I (24-41) (TFA)) | IGF-I (24-41) (Insulin-like Growth Factor I (24-41)) TFA is the amino acid (AA) fragment 24 to 41 of insulin-like growth factor I. | |
|
V137846 | IGF-I (24-41) TFA | IGF-I (24-41) TFA is the amino acid fragment from position 24 to 41 of IGF-I. | |
|
V80352 | IGF-I (30-41) (TFA) (Insulin-like Growth Factor I (30-41) (TFA)) | IGF-I (30-41) (TFA) is the 30 to 41 amino acid (AA) fragment of insulin-like growth factor I. | |
|
V137847 | IGF-I (30-41) TFA | IGF-I (30-41) TFA is the amino acid fragment from position 30 to 41 of insulin-like growth factor I (IGF-I). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
